GlassScriptPrepare for your visit
Caleb Raine
Medical · Atlanta, GA · NPI 1699926899
One page to bring to your appointment. Every figure is as reported to CMS by drug and device makers. Payments are legal and often routine; this is context for a conversation, not a verdict.
What was reported
$1,645.73
in general payments reported to CMS, 2019-2025 · $904 in 2025
The $904 reported for 2025 was more than what 78% of Medical providers received nationally (typical 2025 total: $213).
Who reported paying
General payments only, top 6 by amount.
- Janssen Scientific Affairs, LLC $417.55
- Abbvie INC. $214.58
- Adaptive Biotechnologies Corporation $203.79
- Alexion Pharmaceuticals, INC. $134.70
- Genmab U.S., INC. $121.60
- Kite Pharma, INC. $119.88
Drugs and devices associated with these payments
Carvykti Darzalex Tecvayli Talvey Clonoseq Epkinly Lynozyfic Elrexfio Venclexta Sylvant Adcetris Imfinzi
Association is not allocation: a product listed here means a payment was associated with it, not that money was paid to promote it. Detail covers 2023-2025.
Questions you might ask
- I saw Caleb Raine listed in the CMS Open Payments database. Can you tell me about your work with those companies?
- Is there a generic or alternative to this medication, and would it work as well for me?
- What made you choose this particular treatment for my situation?
These are normal questions. A good clinician will welcome them.
Notes
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.
GlassScript is independent and not affiliated with CMS or any government agency. glasscript.com/doctor/10475280/caleb-raine